Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

Specific keratin gene mutations can cause monilethrix.

A woman with myotonic dystrophy had multiple skin tumors on her scalp, suggesting a genetic link.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Monilethrix severity varies and may be influenced by other genetic or environmental factors.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Primary mitochondrial cytopathies often cause skin, endocrine, vision, and blood issues, needing careful diagnosis.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

A common mutation in the hHb6 gene is linked to monilethrix, but other factors may also play a role.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

Two new gene mutations cause a rare hair disorder.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

A new gene mutation is linked to monilethrix in the studied family.

Mitochondrial DNA from nails and hair can be effectively analyzed for forensic use.

Recognizing minor skin lesions can help identify serious cancer syndromes.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Mutations in the hHb6 gene cause the hair disorder monilethrix.